MAGISTRONI, R. Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease. Giornale di Clinica Nefrologica e Dialisi, [S. l.], v. 29, n. 2, p. 80–84, 2017. DOI: 10.33393/gcnd.2017.660. Disponível em: https://journals.aboutscience.eu/index.php/gcnd/article/view/660. Acesso em: 21 nov. 2024.